CD8 Recombinant Antibody, Cy7 Conjugated
Product Specifications
Background
Identifies cytotoxic/suppressor T-cells that interact with MHC class I bearing targets. CD8 is thought to play a role in the process of T-cell mediated killing. CD8 alpha chains binds to class I MHC molecules alpha-3 domains.
Synonyms
CD8 antigen, alpha polypeptide (p32) ; CD8a; CD8a antigen; CD8a molecule; CD8A_HUMAN; Leu2; Leu2 T lymphocyte antigen; MAL; OKT8 T cell antigen; p32; T cell antigen Leu2; T cell co receptor; T-cell surface glycoprotein CD8 alpha chain; T-lymphocyte differentiation antigen T8/Leu-2; T8 T cell antigen.
Gene ID
925
Swiss Prot
P01732
Cellular Locus
Cell membrane
Host
Rabbit
Cross Reactivity
Human
Target
CD8
Clonality
Recombinant
Conjugation
Cy7
Source
KLH conjugated synthetic peptide derived from human CD8
Applications
WB
Purification
Purified by Protein A.
Excitation Emission
743nm/767nm
Concentration
Lot dependent
Dilution
WB (1:300-5000)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Product Datasheet
https://www.biossantibodies.com/datasheets/bsm-61079R-Cy7
Gene ID URL
925
Isotype
IgG
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6209452-01 0.1 mL
MART-1 (Antigen LB39-AA, Antigen SK29-AA, Melanoma antigen recognized by T-cells 1, MLAN-A, MLANA, Melan-A) (BSA & Azide Free) (MaxLight 490)
Ask
View Details 
MBS6209452-02 5x 0.1 mL
MART-1 (Antigen LB39-AA, Antigen SK29-AA, Melanoma antigen recognized by T-cells 1, MLAN-A, MLANA, Melan-A) (BSA & Azide Free) (MaxLight 490)
Ask
View Details